Asia: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in Asia

The Asian medicaments containing insulin market skyrocketed to $X in 2023, increasing by X% against the previous year. Overall, consumption, however, continues to indicate a pronounced downturn. As a result, consumption reached the peak level of $X. From 2017 to 2023, the growth of the market failed to regain momentum.

Medicaments Containing Insulin Production in Asia

In value terms, medicaments containing insulin production stood at $X in 2023 estimated in export price. The total output value increased at an average annual rate of X% over the period from 2012 to 2023; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. The most prominent rate of growth was recorded in 2017 when the production volume increased by X%. The level of production peaked at $X in 2021; however, from 2022 to 2023, production stood at a somewhat lower figure.

Join Us at HANNOVER MESSE 2024

Don’t miss your chance to connect with us directly. Schedule a personal meeting to dive deeper into how solutions.
Hall 002, Stand C10. 22 - 26 April 2024 | Hannover, Germany

Book Your Meeting

Medicaments Containing Insulin Exports

Exports in Asia

In 2023, approx. X tons of medicaments containing insulin but not antibiotics were exported in Asia; dropping by X% compared with 2022 figures. Overall, exports faced a abrupt shrinkage. The pace of growth appeared the most rapid in 2018 with an increase of X%. Over the period under review, the exports hit record highs at X tons in 2013; however, from 2014 to 2023, the exports remained at a lower figure.

In value terms, medicaments containing insulin exports shrank remarkably to $X in 2023. Over the period under review, exports showed a precipitous contraction. The most prominent rate of growth was recorded in 2020 with an increase of X%. The level of export peaked at $X in 2013; however, from 2014 to 2023, the exports failed to regain momentum.

Exports by Country

Jordan was the key exporting country with an export of about X tons, which recorded X% of total exports. China (X tons) held a X% share (based on physical terms) of total exports, which put it in second place, followed by the United Arab Emirates (X%) and Hong Kong SAR (X%). Thailand (X tons) followed a long way behind the leaders.

From 2012 to 2023, the biggest increases were recorded for China (with a CAGR of X%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, the United Arab Emirates ($X) emerged as the largest medicaments containing insulin supplier in Asia, comprising X% of total exports. The second position in the ranking was held by Jordan ($X), with a X% share of total exports. It was followed by Hong Kong SAR, with a X% share.

In the United Arab Emirates, medicaments containing insulin exports contracted by an average annual rate of X% over the period from 2012-2023. The remaining exporting countries recorded the following average annual rates of exports growth: Jordan (X% per year) and Hong Kong SAR (X% per year).

Export Prices by Country

The export price in Asia stood at $X per ton in 2023, remaining constant against the previous year. In general, the export price recorded a abrupt decrease. The most prominent rate of growth was recorded in 2015 when the export price increased by X%. The level of export peaked at $X per ton in 2016; however, from 2017 to 2023, the export prices stood at a somewhat lower figure.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was the United Arab Emirates ($X per ton), while China ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Hong Kong SAR (X%), while the other leaders experienced a decline in the export price figures.

Medicaments Containing Insulin Imports

Imports in Asia

In 2023, supplies from abroad of medicaments containing insulin but not antibiotics increased by X% to X tons, rising for the second year in a row after three years of decline. Over the period under review, imports, however, showed a deep contraction. The most prominent rate of growth was recorded in 2013 with an increase of X%. Over the period under review, imports reached the peak figure at X tons in 2016; however, from 2017 to 2023, imports failed to regain momentum.

In value terms, medicaments containing insulin imports contracted sharply to $X in 2023. Overall, imports, however, continue to indicate a abrupt downturn. The pace of growth appeared the most rapid in 2013 with an increase of X%. Over the period under review, imports reached the peak figure at $X in 2016; however, from 2017 to 2023, imports failed to regain momentum.

Imports by Country

In 2023, Kuwait (X tons) represented the largest importer of medicaments containing insulin but not antibiotics, mixing up X% of total imports. Myanmar (X tons) ranks second in terms of the total imports with a X% share, followed by Iran (X%). Timor-Leste (X tons) followed a long way behind the leaders.

From 2012 to 2023, average annual rates of growth with regard to medicaments containing insulin imports into Kuwait stood at X%. At the same time, Myanmar (X%) and Timor-Leste (X%) displayed positive paces of growth. Moreover, Myanmar emerged as the fastest-growing importer imported in Asia, with a CAGR of X% from 2012-2023. By contrast, Iran (X%) illustrated a downward trend over the same period. From 2012 to 2023, the share of Kuwait, Myanmar and Timor-Leste increased by X, X and X percentage points, respectively.

In value terms, Kuwait ($X), Myanmar ($X) and Iran ($X) were the countries with the highest levels of imports in 2023, together comprising X% of total imports.

In terms of the main importing countries, Myanmar, with a CAGR of X%, recorded the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The import price in Asia stood at $X per ton in 2023, reducing by X% against the previous year. Over the period under review, the import price, however, continues to indicate a noticeable increase. The pace of growth appeared the most rapid in 2022 an increase of X% against the previous year. The level of import peaked at $X per ton in 2014; however, from 2015 to 2023, import prices stood at a somewhat lower figure.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Myanmar ($X per ton), while Timor-Leste ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Timor-Leste (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform